Infection Surveillance Solutions Market Size to Exceed USD 2,259.6 Mn by 2032

The Infection Surveillance Solutions Market, estimated at USD 892 Mn in 2025, is expected to exhibit a CAGR of 14.2% and reach USD 2,259.6 Mn by 2032.

Market expansion is fueled by growing adoption of digital healthcare solutions, rising demand for efficient data management, and continuous advancements in health IT infrastructure. Increasing integration of electronic health records (EHRs), telehealth platforms, and AI-driven analytics is enhancing patient care, operational efficiency, and decision-making. Strategic collaborations, evolving business models, and supportive regulatory frameworks are creating strong growth prospects for both emerging players and established healthcare IT providers.

The key market players in the market are focusing on the adoption of organic growth strategies, such as product launches to expand their product portfolio, which is expected to drive market growth over the forecast period. For instance, in October 2025, Health Outcomes Worldwide, a software solution company, announced that they had launched the how2trak Surgical Site Infection Surveillance application, which enables surgeons and their teams to monitor their patients remotely to catch early warning signs of infection post-discharge.

Global Infection Surveillance Solutions Market– Impact of Coronavirus (COVID-19) Pandemic

The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2025 as "coronavirus disease 2025" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.

COVID-19 affected the economy in three main ways:  by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries such as India, China, Brazil, and others faced problems with regard to the transportation of drugs from one place to another.

COVID-19 had a positive impact on the global infection surveillance solutions market. For instance, in March 2025, Medtronic, a medical device company announced that they had launched a COVID-19 surveillance application for assessing, monitoring, and triaging people concerned about COVID-19 and potential symptoms. The program assists patients in tracking their respiratory infectious disease symptoms and body temperature with daily health checks.

Global Infection Surveillance Solutions Market: Key Developments

Increasing launch of rapid tests for infection control and surveillance studies is expected to aid in the growth of the global infection surveillance solutions market. For instance, in February 2025, OpGen, Inc. a precision medicine company, announced that it had launched new Research Use Only rapid test for infection control and surveillance studies.

Browse 35 Market Data Tables and 34 Figures spread through 170 Pages and in-depth TOC on “Global Infection Surveillance Solutions Market”- Forecast to 2032, Global Infection Surveillance Solutions Market, by Product and Services (Software, (On-Premises, Web-Based) and Services, (Support & Maintenance, Training & Consulting)), by Infection Type (Surgical Site Infections, Blood Stream Infections, Urinary Tract Infections) by End User (Hospitals, Clinics, Ambulatory Surgical Center, Other (Specialty Center, etc.), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/infection-surveillance-solutions-market-1699

Key Takeaways of the Global Infection Surveillance Solutions Market:

• The global infection surveillance solutions market is expected to exhibit a CAGR of 14.2% during the forecast period due to the increasing emergence of Covid-19. For instance, in October 2025, according to the data published by World Health Organization, there have been 35,659,007 confirmed cases of COVID-19 which increases the demand for monitoring software for infection control and surveillance studies
• Among infection type, surgical site infection segment is estimated to hold a dominant position in the global infection surveillance solutions market over the forecast period.For instance, in August 2025, according to the data published by the Saudi Journal of Medicine and Medical Sciences, a multi-center cross-sectional study among adult patients was conducted in Saudi Arabia to determine the knowledge and awareness of surgical site infection among patients undergoing surgeries. A total of 375 patients were included, out of which 49.1% had good awareness of surgical site infection.
• Among region, North America is expected to be the dominant region in the global infection surveillance solutions market, owing to increasing technological advancement by key market players, to expand the product portfolio and strengthen their market presence, which is expected to drive the segment growth over the forecast period. For instance, in November 2025, Wolters Kluwer N.V., a software solution company, announced that it had expanded the Sentri7 suite of clinical surveillance tools to include Sentri7 Sepsis Monitor. Sentri7 is a web-based platform that aggregates, monitors, and delivers patient data in real-time from disparate hospital information systems to assist providers in delivering optimum patient care.
• Major players operating in the global infection surveillance solutions market include Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences, and Premier